Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...

A new blood test is designed to find mold infections deep inside the body, sparing patients from tissue biopsies.

Issuer: Mainz Biomed N.V. / Key word (s): Miscellaneous Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month 11.02.2025 / 14:01 ...

The launch coincides with March Colorectal Cancer Awareness Month, a global initiative emphasizing the importance of early ...

The ability to predict spirometry-defined COPD was significantly better when a modified lung function questionnaire score was ...

Kayla Funderburg is a 25-year-old hairstylist who is taking control of her breast cancer risk. After a genetic test, she scheduled a double mastectomy.

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

Integration streamlines the implementation process and enhances the clarity and accessibility of results within the EHR, UNC ...

KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, ...

GAITHERSBURG, Md. - GeneDx (NASDAQ: WGS), a genomic insights company valued at $1.64 billion, has launched its services on Aura, Epic's specialty diagnostics suite, to facilitate advanced genetic ...

Regular health screenings play a crucial role in maintaining overall well-being. An STD test in Gurgaon helps detect sexually transmitted infections (STIs) early, ensuring timely treatment and ...

The speed at which food moves through the digestive tract, known as gut transit time, impacts health significantly. It varies among individuals and can be influenced by factors like genetics, diet, ...